Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
Type:
Grant
Filed:
December 5, 2007
Date of Patent:
June 29, 2010
Assignee:
Pomeranian Academy of Medicine
Inventors:
Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski
Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
Type:
Grant
Filed:
June 14, 2004
Date of Patent:
January 15, 2008
Assignee:
Pomeranian Academy of Medicine
Inventors:
Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski